Tonix Pharmaceuticals Stock News

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP ) has entered into a sponsored research agreement with Inserm Transfert and Aix-Marseille Université to study oxytocin in the genetically engineered mouse model of Prader-Willi syndrome (PWS). PWS is a rare genetic disorder that causes distinct but related pathological eating disorders in adults and newborns. "Tonix is excited to enter into … Full story available on Benzinga.com

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) price on Thursday, February 10, rose 1.55% below its previous days close as an upside momentum from buyers pushed the stocks value to $0.22. A look at the stocks price movement, the level at last check in todays session was $0.22, moving within a range at $0.215 and $0.2269. The Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP): On The Right Track To A Higher Share Price Read More »

Are these penny stocks on your watchlist right now? The post Best Penny Stocks to Buy Right Now? 4 to Watch in Mid-February appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt

Are these penny stocks on your watchlist right now? The post Best Penny Stocks to Buy Right Now?

CHATHAM, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Seth Lede

What you need to know about trading penny stocks today The post Trading Penny Stocks? Top Stock Market News For January 19th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information |

What you need to know about trading penny stocks today The post What's Going On in the Stock Market Today, January 19th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | Penny

There may be more reasons than just an overall big day down on the market.

Tonix Pharmaceuticals Holding Corp (TNXP) shares closed 4.2% lower than its previous 52 week low, giving the company a market cap of $152M. The stock is currently down 13.9% year-to-date, down 66.7% over the past 12 months, and down 99.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 19.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1306.5% The company's stock price performance over the past 12 months lags the peer average by 1114.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Tonix Pharmaceuticals Holding Corp (TNXP) shares closed 2.2% lower than its previous 52 week low, giving the company a market cap of $161M. The stock is currently down 8.8% year-to-date, down 60.0% over the past 12 months, and down 99.9% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%. Trading Activity Trading volume this week was 31.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -292.8% The company's stock price performance over the past 12 months lags the peer average by 1890.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Some stocks made a rally the day after a Fed Reserve-fueled sell-off.

CHATHAM, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Seth Lede

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced an exclusive option agreement and research collaboration with Kansas State University (K-State) to develop zinc nanoparticle (ZNP) mR

Are these penny stocks on your January watchlist? The post Are These Penny Stocks on Your January 2022 List? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Are these penny stocks on your January watchlist? The post Are These Penny Stocks on Your January 2022 List?